Glucagon-like Peptide-1 in Type 1 Diabetes

Summary

The hypotheses to be tested in this application is: GLP-1 will acutely protect arterial endothelial function and reduce pro-atherothrombotic and pro-coagulant effects of repeated hypoglycemia in T1DM.

Timeline

Start

2020-06-24

Primary completion

2025-09-24

Completion

2025-09-24

Drugs

Indications